Deferred Tax Assets, Valuation Allowance of BioScience Health Innovations, Inc. from 31 Aug 2019 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
BioScience Health Innovations, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Aug 2019 to 31 Dec 2024.
  • BioScience Health Innovations, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $48,977, a 33% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

BioScience Health Innovations, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $48,977 -$24,178 -33% 31 Dec 2024 10-K 13 Mar 2025 2024 FY
Q4 2023 $73,155 +$42,374 +138% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q4 2022 $30,781 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q3 2022 $24,654 +$17,474 +243% 31 Aug 2022 10-K 01 Nov 2022 2022 FY
Q3 2021 $7,180 +$5,378 +298% 31 Aug 2021 10-K 01 Nov 2022 2022 FY
Q3 2020 $1,802 +$1,613 +853% 31 Aug 2020 10-K 26 Nov 2021 2021 FY
Q3 2019 $189 31 Aug 2019 10-K 25 Nov 2020 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.